Physician

Marjorie Frances Yang, M.D.

According to 2025 Medicare claims, Marjorie Yang, M.D. (NPI: 1891990974) practices dermatology in the Kenosha, WI market, with the plurality of this provider's patient population coming from Kenosha, WI. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1578980165; TIN: 391351587) and primary practice location at 53158-1931.

Yang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 492 traditional Medicare patients, billed 2,977 HCPCS/CPT codes, and received $136,353 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,117 prescription claims across 436 beneficiaries totaling $423,729 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 77 records totaling $868. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $173,112 to $136,353. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $176,319 to $423,729. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$107K$214K2015 Medicare payment: $173,112 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $205,263 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $214,058 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $210,297 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $203,094 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $134,842 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $175,639 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $139,214 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $145,424 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $136,353 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154904,342$173,112
20165334,837$205,263
20175854,697$214,058
20185354,254$210,297
20195643,895$203,094
20204462,992$134,842
20214193,226$175,639
20224462,774$139,214
20234352,898$145,424
20244922,977$136,353

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$281K$562K2015 Drug cost: $176,319 (USD; Tot_Drug_Cst)2016 Drug cost: $189,213 (USD; Tot_Drug_Cst)2017 Drug cost: $343,968 (USD; Tot_Drug_Cst)2018 Drug cost: $457,497 (USD; Tot_Drug_Cst)2019 Drug cost: $441,413 (USD; Tot_Drug_Cst)2020 Drug cost: $515,238 (USD; Tot_Drug_Cst)2021 Drug cost: $562,080 (USD; Tot_Drug_Cst)2022 Drug cost: $273,081 (USD; Tot_Drug_Cst)2023 Drug cost: $356,498 (USD; Tot_Drug_Cst)2024 Drug cost: $423,729 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015282981$176,319
2016321956$189,213
20173621,009$343,968
20183371,070$457,497
20193851,077$441,413
2020353998$515,238
2021316864$562,080
2022368899$273,081
2023353877$356,498
20244361,117$423,729

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths100131$78
11102Biopsy of related skin growth, first growth133163$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more347559$59
17000Destruction of precancer skin growth, 1 growth206334$37
17003Destruction of precancer skin growth, 2-14 growths1451,020$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa11924$217,258
OtezlaApremilast22660$93,573
Taltz AutoinjectorIxekizumab11308$74,359
Clobetasol PropionateClobetasol Propionate852,038$2,925
KetoconazoleKetoconazole1915,294$2,773

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.77$868ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marjorie Frances Yang, M.D.?

Tedicare shows public-source Medicare data for Marjorie Frances Yang, M.D. (NPI 1891990974), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marjorie Frances Yang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marjorie Frances Yang, M.D.?

Marjorie Frances Yang, M.D. is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1578980165) in the available physician profile data.

Does Marjorie Frances Yang, M.D. have Open Payments data?

Marjorie Frances Yang, M.D. has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.